INTERNATIONAL PATENT: KIND PHARMACEUTICAL, 杭州安道药业有限公司 FILES APPLICATION FOR "USE OF HYPOXIA-INDUCIBLE FACTOR-PROLYL HYDROXYLASE INHIBITOR (HIF-PHI) IN RARE ANEMIA"

GENEVA, May 5 -- KIND PHARMACEUTICAL (Rm512, South Building, #2 East Chaofeng Rd, Economic-technological Development Area, Linping DistrictHangzhou, Zhejiang 311100), 杭州安道药业有限公司 (中国浙江省杭州市临平区经济开发区超峰东路2号南楼512室) filed a patent application (PCT/CN2024/126291) for "USE OF HYPOXIA-INDUCIBLE FACTOR-PROLYL HYDROXYLASE INHIBITOR (HIF-PHI) IN RARE ANEMIA" on Oct 22, 2024. With publication no. WO/2025/087208, the details related to the patent application was published on May 01, 2025.

Notably, the patent application ...